Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

CDR 101

Next Previous
Drug Profile

CDR 101

Alternative Names: CDR-101

Latest Information Update: 19 Dec 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator CDR-Life
  • Class Antineoplastics; Immunoglobulin Fv fragments; Immunotherapies; Trispecific antibodies
  • Mechanism of Action B-cell maturation antigen antagonists; CD3 antigen inhibitors; Programmed cell death-1 ligand-1 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Multiple myeloma

Most Recent Events

  • 13 Dec 2021 CDR-Life plans to initiate IND-enabling activities for CDR 101
  • 13 Dec 2021 Pharmacodynamics data from preclinical trials in Multiple myeloma presented at the 63rd Annual American Society of Hematology meeting (ASH-2021)
  • 11 Dec 2021 Pharmacodynamics data from preclinical trials in Multiple myeloma presented at the 63rd Annual American Society of Hematology meeting (ASH-2021)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top